Skip to main content

Table 1 Characteristics of study subjects included for overall analysis

From: A novel workflow combining plaque imaging, plaque and plasma proteomics identifies biomarkers of human coronary atherosclerotic plaque disruption

 

PCI

Diagnostic angiography

Number (male)

58 (46)

23 (16)

Age [years (SD)]

66 (11)

68 (10)

Acute coronary syndrome [n (%)]

21 (36)

13 (57)

Smoking status [n (%)]

 Current smoker

16 (28)

3 (13)

 Ex-smoker >1 month

25 (43)

13 (57)

 Never smoked

17 (29)

7 (30)

Past history of IHD [n (%)]

 MI/ACS

22 (38)

7 (30)

 Stable angina

15 (26)

7 (30)

Hypertension [n (%)]

39 (67)

19 (83)

Hypercholesterolemia [n (%)]

45 (78)

13 (57)

Diabetes mellitus [n (%)]

14 (24)

4 (17)

Family history of IHD [n (%)]

29 (50)

12 (52)

Regular medication [n (%)]

 Aspirin

40 (69)

17 (74)

 Thienopyridine

23 (40)

11 (48)

 Statin

47 (81)

20 (87)

 β-blocker

33 (57)

14 (61)

 ACE inhibitor/ARB

38 (65)

19 (83)